Nephrology Dialysis Transplantation · 1988 · 18 citations · 31 references
MedicineHematologyNephrologyDialysisHemodialysisRenal Replacement TherapyChronic HemodialysisComplement RegulationComplement SystemComplement-mediated InjuryDialyzer MembranesNeutrophil BiologyBlood Loss In HemodialysisCellulose Acetate MembranesComplement Activation PathwaysCuprophan MembranesInflammation In HemodialysisInflammatory Responses To HemodialysisNeutrophil InvolvementNeutrophil Physiology
A prospective study was undertaken in 12 haemodialysed patients successively treated on five new as well as re-used dialyser membranes, that is cuprophane, cellulose acetate, polysulphone, polycarbonate, and polyacrylonitrile. A significant reduction of neutrophils occurred with every membrane during their first use, which improved only with cuprophane upon re-use. Thrombocytopenia was noted only when neutropenia reached very low values. Monocyte reduction occurred on cuprophane, cellulose acetate and polycarbonate, but did not improve during second use. C3d accumulation paralleled the time course of neutropenia only with cuprophane and cellulose acetate. Plasma collected at the extreme of neutropenia induced aggregation of control and predialysis cells, but did not aggregate autologous dialysed neutrophils collected at 5 min. Our data indicate that the mechanism linking complement activation to neutropenia is probably triggered by more than one factor.
31
Complement and Leukocyte-Mediated Pulmonary Dysfunction in Hemodialysis
Philip R. Craddock, Jörg Fehr, Kenneth L. Brigham et al. · New England Journal of Medicine · 1977 · 1K citations
Medicine, Nephrology, Physiology +17
M. Markert, Patricia C. Andrews, Bernard Babior · Methods in enzymology on CD-ROM/Methods in enzymology · 1984 · 356 citations
Luc Perrin, P H Lambert, P. A. Miescher · Journal of Clinical Investigation · 1975 · 268 citations · Full text
Life Sciences, Immunology, Pathology +17